Trifluoroacetohydrazide → Ethyl 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine-7-carboxylate
반응식
S=[C:2]1[CH2:7][CH:6]([C:8]([O:10][CH2:11][CH3:12])=[O:9])[CH2:5][CH2:4][NH:3]1.[F:13][C:14]([F:20])([F:19])[C:15]([NH:17][NH2:18])=O>C1COCC1.[Hg](OC(C)=O)OC(C)=O>[F:13][C:14]([F:20])([F:19])[C:15]1[N:3]2[CH2:4][CH2:5][CH:6]([C:8]([O:10][CH2:11][CH3:12])=[O:9])[CH2:7][C:2]2=[N:18][N:17]=1참가 물질
5
실험 절차
To a solution of ethyl 2-thioxopiperidine-4-carboxylate (5.7 g, 14.95 mmol) in THF (203 mL) was added 2,2,2-trifluoroacetohydrazide (7.8 g, 60.88 mmol) and Hg(OAc)2 (10.71 g, 33.48 mmol) at ice-water. The mixture was stirred at room temperature for 2 hours and heated at 60° C. for overnight, then filtered. Removed the solvent under reduced pressure and the filtrate was concentrated and purified by silica gel column chromatography (PE/EA=3/1) to afford ethyl 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine-7-carboxylate (3.5 g, yield 43.8%). 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.10-1.32 (m, 3H) 2.16 (br. s., 1H) 2.36 (br. s., 1H) 2.93 (br. s., 1H) 3.02-3.39 (m, 2H) 3.90-4.30 (m, 4H).
후처리
- temperatureheated at 60° C. for overnight
- filtrationfiltered
- customRemoved the solvent under reduced pressure
- concentrationthe filtrate was concentrated
- custompurified by silica gel column chromatography (PE/EA=3/1)
출처 및 근거
- ORD 기록
- ord-267e07dbb5154f9fbe390e4ebde26203
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09446130B2
반응 노트
불러오는 중…